Mirae Asset Global Etfs Holdings Ltd. Verrica Pharmaceuticals Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,591 shares of VRCA stock, worth $171,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,591
Previous 10,856
98.89%
Holding current value
$171,648
Previous $86,000
98.84%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VRCA
# of Institutions
73Shares Held
20.3MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.57MShares$68.1 Million1.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.81MShares$22.3 Million0.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$8.1 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...